January 11: COVID-19 Update

The Culpeper’s leadership team continues to thank you for your support as we navigate the latest surge in COVID-19 cases.

Current positive results to report are as follows:
• One assisted living non-direct care team member who last worked on 1/10/22.
• One healthcare direct care team member who last day worked on 1/9/22.
• One rehab-to-home resident.

All COVID-19 positive team members will remain at home until return-to-work criteria are met. Contact tracing has been completed for all team members. All identified high-risk team members will be tested per Centers for Medicare and Medicaid Services (CMS) guidance testing protocol and will be closely observed for symptoms of the virus. No resident high-risk exposures have been identified.

The COVID-19 positive resident has been placed in isolation. All identified high-risk residents have been tested on this date with no additional positives to report. Communal activities and dining have been suspended in the rehab-to-home neighborhood at this time as an added precaution. Per new CMS guidance, visitation will not be discontinued, although visitors are urged to strongly consider the need for visitation to rehab-to-home at this time.

The Culpeper’s terrace level remains in outbreak testing with the next testing date for residents and team members set for January 13. Residents and team members in assisted living and memory support will be tested based on symptoms or exposure. Any team members who are not yet fully vaccinated or have received a medical or religious waiver from LifeSpire of Virginia will continue to be tested based on the county transmission rate. The leadership team will communicate any further positive cases.

All licensing agencies and the Virginia Department of Health have been notified of the positive cases and subsequent actions taken by The Culpeper.
Check the COVID-19 communications hub at https://culpeperretirement.org/blog/covid19/ for up-to-date communications. Please direct questions to Executive Director Jim Jacobsen at [email protected] or (540) 825-2411.